NorthCrest Asset Manangement’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
AAMU
QCM
CIM
GIC
CNB
CAMG
GC
NorthCrest Asset Manangement's BIIB Position: Q2 2026 in Review
NorthCrest Asset Manangement increased its Biogen (BIIB) stake by 3.4% in Q2 2026, buying an estimated $162K and bringing the position to 25,857 shares worth $5.14M. The position accounts for 0.13% of the portfolio, ranked #140.
NorthCrest Asset Manangement first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.94M in Q2 2023. 131 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- NorthCrest Asset Manangement held 25,857 shares of Biogen worth $5.14M as of Q2 2026.
- NorthCrest Asset Manangement bought 845 Biogen shares in Q2 2026, an estimated $162K.
- Biogen made up 0.13% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #140 holding.
- NorthCrest Asset Manangement first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
- NorthCrest Asset Manangement's Biogen position peaked at $8.94M in Q2 2023.
- 131 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.